Covista (CVSA) Liabilities and Shareholders Equity (2009 - 2026)

Covista (CVSA) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $2.7 billion in Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $2.7 billion, down 1.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.0 billion (down 0.9% YoY), and the FY2025 annual result was $2.8 billion, changed 0.4% from the prior year.
• Liabilities and Shareholders Equity rose to $2.7 billion in Q1 2026 per CVSA's latest filing, from $2.6 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $3.5 billion in Q1 2022 and troughed at $2.6 billion in Q4 2025.
• A 5-year average of $2.8 billion and a median of $2.8 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
• On a YoY basis, Liabilities and Shareholders Equity climbed as much as 14.96% in 2022 and fell as far as 22.29% in 2022.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $2.8 billion in 2022, then dropped by 5.03% to $2.7 billion in 2023, then rose by 0.82% to $2.7 billion in 2024, then slipped by 3.98% to $2.6 billion in 2025, then climbed by 4.69% to $2.7 billion in 2026.
• Business Quant data shows CVSA's Liabilities and Shareholders Equity at $2.7 billion in Q1 2026, $2.6 billion in Q4 2025, and $2.9 billion in Q3 2025.